This link will take you to a page that’s not on LinkedIn

Because this is an external link, we’re unable to verify it for safety.

https://www.gentibio.com/press_releases/gentibio-to-highlight-clinical-stage-gnti-122-polaris-study-and-next-generation-allogeneic-platform-and-programs-at-2026-american-society-for-cell-and-gene-therapy-asgct-annual-meeting/